Insiders at Irish-based Icon had motive to sell €74m shares at ‘artificially inflated price’, US lawsuit claims
Company says it will ‘vigorously’ defend class action suit alleging it made ‘materially false and misleading’ statements on ...
Pfizer's CEO says he's got a plan to deal with Trump's tariffs — move overseas drug manufacturing to the US
"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...